
Opinion|Videos|March 28, 2025
Looking Ahead: Future Landscape for Treating OFF Time and Dyskinesia
Author(s)Daniel E. Kremens, MD, JD
An expert discusses D1 receptor agonists that reduce negative symptoms and the increasing availability of recent and upcoming PUMP options for Parkinson disease treatment.
Advertisement
Episodes in this series

Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy
2
Enhancing Biomarker Use and Targeted Treatment Approaches in Alzheimer Disease: Aaron Burstein, PharmD
3
Early Opicapone Initiation in Parkinson Leads to Continued Long-Term Therapeutic Benefits
4
What the EC Decision on High-Dose Spinraza Means for SMA Care
5



























